Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Long Chen

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Molecular & Cellular Proteomics : MCP|March 20, 2014
Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profilingMari Masuda, Wei-Yu Chen, Akihiko Miyanaga, et al.
Current Opinion in Chemical Biology|March 15, 2021
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatmentYao-An Shen, Chi-Long Chen, Yi-Hsuan Huang, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Journal of the Chinese Medical Association : JCMA|December 11, 2020
Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosisWei-Yu Kao, Yuan-Feng Lin, I-Wei Chang, et al.
The American Journal of Pathology|September 15, 2012
Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasisYa-Ching Chou, Chi-Long Chen, Te-Huei Yeh, et al.
Oncotarget|January 12, 2017
Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapyYu-Chieh Lee, Chia-Yu Su, Yuan-Feng Lin, et al.
Journal of Nanobiotechnology|October 10, 2021
Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatmentMing-Hsien Chan, Chih-Ning Lu, Yi-Lung Chung, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 9, 2002
Expression of Epstein-Barr virus latent membrane protein 1 and B-cell leukemia-lymphoma 2 gene in nasopharyngeal carcinoma tissuesJohn Jenn-Yenn Lu, Chi-Long Chen, Tsuey-Ying Hsu, et al.
Journal of Extracellular Biology|June 28, 2024
RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancerYu-Chan Chang, Yi-Fang Yang, Chien-Hsiu Li, et al.
American Journal of Clinical Pathology|November 13, 2004
Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessmentSu-Peng Yeh, Yu-Mine Liao, Chang-Hu Hsu, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Molecular & Cellular Proteomics : MCP|March 20, 2014
Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profilingMari Masuda, Wei-Yu Chen, Akihiko Miyanaga, et al.
Current Opinion in Chemical Biology|March 15, 2021
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatmentYao-An Shen, Chi-Long Chen, Yi-Hsuan Huang, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Journal of the Chinese Medical Association : JCMA|December 11, 2020
Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosisWei-Yu Kao, Yuan-Feng Lin, I-Wei Chang, et al.
The American Journal of Pathology|September 15, 2012
Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasisYa-Ching Chou, Chi-Long Chen, Te-Huei Yeh, et al.
Oncotarget|January 12, 2017
Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapyYu-Chieh Lee, Chia-Yu Su, Yuan-Feng Lin, et al.
Journal of Nanobiotechnology|October 10, 2021
Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatmentMing-Hsien Chan, Chih-Ning Lu, Yi-Lung Chung, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 9, 2002
Expression of Epstein-Barr virus latent membrane protein 1 and B-cell leukemia-lymphoma 2 gene in nasopharyngeal carcinoma tissuesJohn Jenn-Yenn Lu, Chi-Long Chen, Tsuey-Ying Hsu, et al.
Journal of Extracellular Biology|June 28, 2024
RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancerYu-Chan Chang, Yi-Fang Yang, Chien-Hsiu Li, et al.
American Journal of Clinical Pathology|November 13, 2004
Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessmentSu-Peng Yeh, Yu-Mine Liao, Chang-Hu Hsu, et al.
Pageof 14